Phase III Gazyva Trial Fails to Meet Primary Endpoint of Improving PFS in DLBCL August 04, 2016Vol.39 No.07
Trial: Erbitux-FOLFOX Therapy Improves PFS, OS in RAS Wild-Type Colorectal Cancer August 04, 2016Vol.39 No.07
Niraparib Demonstrates Prolonged PFS In Phase III Trial, Achieving Primary Endpoint August 04, 2016Vol.39 No.07
Drugs & Targets Mylan and Biocon submit marketing application to EMA for biosimilar Pegfilgrastim July 29, 2016Vol.42 No.30
Drugs & Targets CHMP Issues Positive Opinion for Onivyde Combination in Pancreatic Adenocarcinoma July 29, 2016Vol.42 No.30
Funding Opportunities Shire, ACMG Foundation Offering Fellowships in Medical Genetics July 29, 2016Vol.42 No.30
